Last searches
Results for *
Displaying results 1 to 25 of 34.
-
ReVac: a reverse vaccinology computational pipeline for prioritization of prokaryotic protein vaccine candidates
-
Making markets for vaccines
ideas to action ; the report of the Center for Global Development, Advance Market Commitment Working Group. Ruth Levine, Michael Kremer, Alice Albright, co-chairs. [Lead report authors Owen Barder ...] -
Health policy and technological change
-
Analysis of COVID-related patents for antibodies and vaccines
-
The Return of the "Cult"
-
Remittances and vaccine hesitancy in the Punjab Province of Pakistan
-
The impact of vaccines and behavior on U.S. cumulative deaths from COVID-19
-
Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery
-
COVID-19 vaccines as global public goods
between life and profit -
The WTO TRIPS decision on COVID-19 vaccines
what is needed to implement it? -
Left on our own
COVID-19, TRIPS-Plus Free Trade Agreements, and the Doha Declaration on TRIPS and Public Health -
Covid-19 and output in Japan
-
Why are drugs more profitable than vaccines?
-
Post-neonatal mortality impacts following grants from the Gavi Vaccine Alliance
an econometric analysis from 2000 to 2014 -
Can negotiations at the World Health Organization lead to a just framework for the prevention, preparedness and response to pandemics as global public goods?
-
Covid-19 vaccines, innovation, and intellectual property rights
-
¿Podrán las negociaciones en la organización mundial de la salud resultar en un marco justo para la prevención, la preparación y la respuesta ante pandemias como bienes públicos globales?
-
Les négociations au sein de l'Organisation mondiale de la santé peuvent-elles aboutir à un cadre juste pour la prévention, la préparation et la riposte aux pandémies en tant que bien public mondial?
-
Financing research and development for new vaccines in Asia-Pacific developing countries
-
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
-
Guía para la concesión de licencias obligatorias y uso gubernamental de patentes farmacéuticas
-
International evidence on vaccines and the mortality to infections ratio
-
Covid-19 and output in Japan
-
Contagion at work
-
How COVID-19 vaccine supply chains emerged in the midst of a pandemic